Mechanisms Involved in Glucagon-Like Peptide-1 (7–36) Amide Action on the Rat Hypothalamo-Neurohypophysial System

Publisher： Karger

E-ISSN： 1423-0194|77|2|119-124

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.77, Iss.2, 2003-03, pp. : 119-124

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Glucagon-Like Peptide 1 (7–36 Amide) on Glucose Kinetics during Somatostatin-Induced Suppression of Insulin Secretion in Healthy Men

By  

Hormone Research in Paediatrics, Vol. 49, Iss. 5, 1998-04 ,pp. : 221-225

Karger

Access to resources Recommend Favorite

Glucagon-Like Peptide-1 Agonist Exendin-4 Leads to Reduction of Weight and Caloric Intake in a Rat Model of Hypothalamic Obesity

By  

Hormone Research in Paediatrics, Vol. 78, Iss. 1, 2012-07 ,pp. : 47-53

Karger

Access to resources Recommend Favorite

Treatment with Glucagon-Like Peptide-1 Agonist Exendin-4 in a Patient with Hypothalamic Obesity Secondary to Intracranial Tumor

By  

Hormone Research in Paediatrics, Vol. 78, Iss. 1, 2012-07 ,pp. : 54-58

Karger

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Transactivation Is Necessary for Glucagon-Like Peptide-1 to Protect PC12 Cells from Apoptosis

By  

Neuroendocrinology, Vol. 97, Iss. 4, 2012-12 ,pp. : 300-308

Karger

Access to resources Recommend Favorite

Effects of Galanin-Like Peptide on Food Intake and the Hypothalamo-Pituitary-Thyroid Axis

By  

Neuroendocrinology, Vol. 77, Iss. 2, 2003-03 ,pp. : 125-131

Karger

Access to resources Recommend Favorite